PITTSBURGH POST-GAZETTE | Within the arena of public health battles, all eyes are peeled on COVID-19. But another health crisis looms: a war against drug-resistant infections. This Editorial quotes Jonathan Steckbeck, CEO of Peptilogics, on the challenges that antibacterial drug developers face. It urges the US government to proceed with the PASTEUR Act, which would not only restructure the US federal payment protocol, it also would boost data collection by hospitals which would receive federal funding for participating in an anti-overuse program.